Daston G P, Overmann G J, Taubeneck M W, Lehman-McKeeman L D, Rogers J M, Keen C L
Miami Valley Laboratories, Procter & Gamble Company, Cincinnati, Ohio 45239.
Toxicol Appl Pharmacol. 1991 Sep 15;110(3):450-63. doi: 10.1016/0041-008x(91)90046-h.
We hypothesize that maternal metallothionein (MT) induction by toxic dosages of chemicals may contribute to or cause developmental toxicity by a chain of events leading to a transient but developmentally adverse decrease in Zn availability to the embryo. This hypothesis was tested by evaluating hepatic MT induction, maternal and embryonic Zn status, and developmental toxicity after exposure to urethane, a developmental toxicant, or styrene, which is not a developmental toxicant. Pregnant Sprague-Dawley rats were given 0 or 1 g/kg urethane ip, or 0 or 300 mg/kg styrene in corn oil po, on Gestation Day 11 (sperm positive = Gestation Day 0). These were maternally toxic dosages. As both treatments decreased food consumption, separate pair-fed control groups were also evaluated for effects on MT and Zn status and development. In addition, Gestation Day 11 rat embryos were exposed to urethane in vitro in order to determine whether urethane has the potential to be directly embryotoxic. Urethane treatment induced hepatic MT 14-fold over control; styrene treatment induced MT 2.5-fold. The MT induction by styrene could be attributed to decreased food intake, as a similar level of induction was observed in a pair-fed untreated control group. However, the level of MT induction by urethane was much greater than that produced by decreased food intake alone. Hepatic Zn concentration, particularly in the cytosol, was increased in the presence of increased hepatic MT concentration. Plasma Zn concentration was significantly decreased (approximately 30%) by urethane treatment, but not by styrene or food restriction (pair-feeding). Distribution of 65Zn to the liver of urethane-treated dams was significantly greater (by 30%), while distribution to embryonic tissues was significantly lower (by at least 50%) than in pair-fed or ad lib.-fed controls. Styrene treatment had no effect on 65Zn distribution. Urethane was developmentally toxic, causing an 18% decrease in fetal weight and a significant delay in skeletal ossification, but was not toxic to rat embryos in vitro. Styrene was not developmentally toxic. The changes observed after urethane treatment, namely substantial hepatic MT induction and altered maternal and embryonic Zn status, along with the lack of direct embryotoxicity of urethane in vitro, support the hypothesis that these maternal effects contribute to developmental toxicity. The lack of similar changes in styrene-intoxicated dams provides one explanation for its low developmental toxicity at maternally toxic dosages.
我们假设,化学物质的毒性剂量诱导母体金属硫蛋白(MT),可能通过一系列事件导致胚胎可利用锌的短暂但对发育不利的减少,从而促成或导致发育毒性。通过评估接触氨基甲酸乙酯(一种发育毒物)或苯乙烯(一种非发育毒物)后的肝脏MT诱导、母体和胚胎锌状态以及发育毒性,对这一假设进行了检验。在妊娠第11天(精子阳性=妊娠第0天),给怀孕的斯普拉格-道利大鼠腹腔注射0或1 g/kg氨基甲酸乙酯,或经口灌胃0或300 mg/kg苯乙烯于玉米油中。这些都是母体毒性剂量。由于两种处理都降低了食物摄入量,还评估了单独的配对喂养对照组对MT和锌状态以及发育的影响。此外,在体外将妊娠第11天的大鼠胚胎暴露于氨基甲酸乙酯,以确定氨基甲酸乙酯是否有可能直接产生胚胎毒性。氨基甲酸乙酯处理使肝脏MT诱导水平比对照组高14倍;苯乙烯处理使MT诱导水平高2.5倍。苯乙烯诱导MT可归因于食物摄入量减少,因为在未处理的配对喂养对照组中观察到了类似的诱导水平。然而,氨基甲酸乙酯诱导的MT水平远高于仅由食物摄入量减少所产生的水平。在肝脏MT浓度增加的情况下,肝脏锌浓度,特别是胞浆中的锌浓度升高。氨基甲酸乙酯处理使血浆锌浓度显著降低(约30%),但苯乙烯或食物限制(配对喂养)未使其降低。与配对喂养或自由采食对照组相比,氨基甲酸乙酯处理的母鼠肝脏对65Zn的摄取显著增加(增加30%),而胚胎组织中的摄取显著降低(至少降低50%)。苯乙烯处理对65Zn分布无影响。氨基甲酸乙酯具有发育毒性,导致胎儿体重下降18%,骨骼骨化显著延迟,但在体外对大鼠胚胎无毒。苯乙烯无发育毒性。氨基甲酸乙酯处理后观察到的变化,即肝脏MT大量诱导以及母体和胚胎锌状态改变,以及氨基甲酸乙酯在体外缺乏直接胚胎毒性,支持了这些母体效应促成发育毒性的假设。苯乙烯中毒母鼠缺乏类似变化,为其在母体毒性剂量下发育毒性低提供了一种解释。